Aerbio, billed as a pioneer in fermentation technology, has begun its pilot line as it steps up its development.
The company – which plans to raise up to €50m in a Series A funding round, with the target close set for Q4 – uses carbon dioxide (CO2) and hydrogen in the same way most fermentation processes use sugar to produce Proton™, a protein-rich ingredient which could ‘revolutionise’ food and animal nutrition, with no need for fertile soil.
The newly formed company comes as part of a buyout of UK-headquartered Deep Branch Biotechnology, with the core management team of Kaspar Kristiansen (CEO), Rob Mansfield (CTO) and Peter Rowe (CXO), and Chairperson Lars Topholm retained to forge a new path for the business.
Rowe said it is clear there is a pressing need for scalable, nutritious and sustainable protein sources for a range of applications, most notably human and animal nutrition. Collaborations include aquafeed producer BioMar.
... to continue reading you must be subscribed
